No Result
View All Result
  • Login
Sunday, September 6, 2026
FeeOnlyNews.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
FeeOnlyNews.com
No Result
View All Result
Home Business

Bearish Tesla analyst has good news for Rivian stock investors

by FeeOnlyNews.com
5 months ago
in Business
Reading Time: 4 mins read
A A
0
Bearish Tesla analyst has good news for Rivian stock investors
Share on FacebookShare on TwitterShare on LInkedIn


Analysts at BNP Paribas have been pretty steady on Tesla, making the Wall Street firm one of the few with a bearish outlook on the stock.

BNP Paribas has an underperform rating and a $280 price target on the stock (compared to the consensus hold rating and $397.26 price target, according to MarketBeat), based on skepticism about the company’s Robotaxi and Optimus-focused plans for 2026.

BNPP analysts are very skeptical of the progress, or lack thereof, that Tesla is showing in Robotaxi and humanoid robots. According to the firm, Tesla’s Robotaxi growth in Austin and San Francisco has “stagnated,” and it seems skeptical of the company’s expansion into Dallas and Houston, referring to its “launches” with quotation marks.

Analysts said Tesla will also “require a steep ramp” to reach the 7-city expansion by the end of the year, which CEO Elon Musk promised investors during the company’s previous earnings call.

“We also don’t see much progress in Optimus commercialization,” analysts said, referring to Musk’s other promise of expanding the company’s capacity to build 1 million Optimus humanoid robots per year.

“Given Tesla’s sizable cash burn this year ($7 billion estimate by BNPP) and indications for massive multi-year investments on the horizon tied to a TeraFab and 100 GW solar capacity, the ‘stakes’ of TSLA’s demonstrated Robotaxi and Optimus progress could not be higher,” analysts said in a recent note.

Meanwhile, analysts at the firm are bullish on domestic Tesla EV rival Rivian, despite the fact that the company lags far behind Tesla. BNPP’s goals for Rivian by the end of the year are milestones Tesla has already mastered.

Elon Musk has promised investors that Tesla will more than triple its Robotaxi coverage and usher in the humanoid robot revolution by the end of the year. Meanwhile, Rivian’s goals this year seem much more attainable, so analysts at BNP Paribas are more bullish on the struggling startup EV maker.

Rivian has a $23 price target on its shares, 26% above the stock’s closing price of $16.92 on Monday, April 20.

More EV news

The firm says that while it expects better deliveries, “Rivian’s 2026 will be defined by… the Co.’s ability to offer FSD-like ‘point-to-point’ hands-free driving by year end.”

In the meantime, it says the recent $1.25 billion expanded Robotaxi partnership with Uber is enough to push the firm’s expectations for Rivian’s stock to $4 per share.

Story Continues

During its Autonomy & AI Day in December, Rivian introduced the Gen 3 Autonomy Computer, its third-generation compute platform, which it says will have the “leading combination of vehicle sensors and inference available in North America.”

The Gen 3 Autonomy Computer can process 5 billion pixels per second, thanks to the Rivian Autonomy Processor, its proprietary silicon chip that Rivian claims is among the first multi-chip modules used in high-compute automotive applications.

All Rivian vehicle deliveries now come with a 60-day trial of Autonomy+, its hands-free platform.

Analysts at BNP Paribas are bullish on domestic Tesla EV rival Rivian.Photo by 400tmax on Getty Images

Tesla shares had a rough session on April 20, dropping more than 2%, but the stock is still up nearly 10% over the past five sessions as it heats up heading into earnings on Wednesday, April 22.

The stock is still down 10.4% year to date, but it has seen a definite uptick in recent days.

Barclays analysts maintained an equal-weight rating and $360 price target on the electric vehicle maker, while TD Cowen analysts were bullish on the stock in separate recent notes.

“Barclays believes Terafab could cost in the mid-single-digit trillion-dollar range if fully built out. While Tesla’s capex is unlikely to ‘exponentially increase,’ a further step up from the elevated $20B figure Tesla talked to on the last earnings call is likely,” Barclays contends.

Barclays analysts pin the recent stock sell-off on a lack of guidance about the company’s Robotaxi and Optimus progress. Tesla said earlier this year it was mothballing its Model S and Model X brands to focus on robotics and AI.

According to the firm, the sell-off “could imply on the surface an opportunity for the stock to outperform” after the Q1 results are released. Barclays, however, says it takes a “more tempered view into the print,” as any suggestions of incremental capex spending “could be perceived negatively.”

Meanwhile, analysts at TD Cowen remained bullish on the company, maintaining its buy rating, while lowering its price target to $490 from $519.

The firm agrees that the lack of news about progress on Robotaxi and Optimus has “dampened sentiment” heading into the Q1 print. It also sees Tesla as better positioned than suppliers to offer investors “reassurances” and retain “guidance credibility.”

TD Cowen believes Tesla has a low risk of guiding down in the earnings call and sees a slightly positive setup for the stock heading into the earnings release on Wednesday, April 22.

Related: Rivian defies expectations despite rough EV environment

This story was originally published by TheStreet on Apr 21, 2026, where it first appeared in the Automotive section. Add TheStreet as a Preferred Source by clicking here.



Source link

Tags: AnalystBearishgoodinvestorsNewsRivianstockTesla
ShareTweetShare
Previous Post

10 Best Dividend Growth Stocks Now

Next Post

Banks fund crypto attack ads across Washington as over 3,000 banks unite to stop Clarity Act passing Senate

Related Posts

Advanced Micro Devices (AMD) Price Prediction: How Much a ,000 Investment Could Be Worth by 2031

Advanced Micro Devices (AMD) Price Prediction: How Much a $5,000 Investment Could Be Worth by 2031

by FeeOnlyNews.com
August 8, 2026
0

Quick Read AMD's Data Center revenue jumped 57% YoY, driving a base-case projection of $7,657 from a $5,000 investment by...

Vanguard Chief Economist: AI and jobs, still in an ATM phase

Vanguard Chief Economist: AI and jobs, still in an ATM phase

by FeeOnlyNews.com
August 8, 2026
0

Every wave of technological change seems to arrive with a familiar prediction: This time, jobs are going away for good....

Explained: How BSE traded fewer contracts after CAS but premiums rose 75% in first week

Explained: How BSE traded fewer contracts after CAS but premiums rose 75% in first week

by FeeOnlyNews.com
August 8, 2026
0

Asia's oldest exchange, BSE, traded far fewer derivatives contracts in the first week following the implementation of the Closing Auction...

Banks or NBFCs? DSP’s Preethi R S explains where she sees the best opportunities

Banks or NBFCs? DSP’s Preethi R S explains where she sees the best opportunities

by FeeOnlyNews.com
August 8, 2026
0

India’s financial stocks are entering a more selective phase, where the strength of a lender’s deposit franchise, underwriting discipline and...

Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding (OTCMKTS:VXRT)

Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding (OTCMKTS:VXRT)

by FeeOnlyNews.com
August 7, 2026
0

Earnings Call Insights: Vaxart, Inc. (VXRT) Q2 2026 Management View "The second quarter and recent weeks marked a pivotal period...

Nutex outlines 3 hospital openings in H2 2026 while maintaining 3 to 5 openings per year (NASDAQ:NUTX)

Nutex outlines 3 hospital openings in H2 2026 while maintaining 3 to 5 openings per year (NASDAQ:NUTX)

by FeeOnlyNews.com
August 7, 2026
0

Earnings Call Insights: Nutex Health (NUTX) Q2 2026 Management View "It was an active quarter, marked by strong financial results,...

Next Post
Banks fund crypto attack ads across Washington as over 3,000 banks unite to stop Clarity Act passing Senate

Banks fund crypto attack ads across Washington as over 3,000 banks unite to stop Clarity Act passing Senate

White House discussing currency swap line with UAE

White House discussing currency swap line with UAE

  • Trending
  • Comments
  • Latest
Bitcoin and ethereum prices today, Friday, August 7, 2026: Crypto prices moving higher following July jobs report

Bitcoin and ethereum prices today, Friday, August 7, 2026: Crypto prices moving higher following July jobs report

August 7, 2026
MEXC Lists Ondo Yield Asset As Tokenized Treasury Demand Grows

MEXC Lists Ondo Yield Asset As Tokenized Treasury Demand Grows

July 3, 2026
Delek Logistics Partners Reports alt=

Delek Logistics Partners Reports $0.54 EPS for Q2 FY26

August 5, 2026
Onkure Therapeutics Releases Q2 2026 Financial Results

Onkure Therapeutics Releases Q2 2026 Financial Results

August 4, 2026
Thryv outlines M run-rate savings while revising 2026 SaaS adjusted EBITDA to M-M (NASDAQ:THRY)

Thryv outlines $60M run-rate savings while revising 2026 SaaS adjusted EBITDA to $42M-$44M (NASDAQ:THRY)

August 4, 2026
My Thoughts on Going All In

My Thoughts on Going All In

August 4, 2026
Advanced Micro Devices (AMD) Price Prediction: How Much a ,000 Investment Could Be Worth by 2031

Advanced Micro Devices (AMD) Price Prediction: How Much a $5,000 Investment Could Be Worth by 2031

0
Cities holding up to 3 million people found under Amazon rain forest

Cities holding up to 3 million people found under Amazon rain forest

0
Republican Party Displacement | Mises Institute

Republican Party Displacement | Mises Institute

0
Bybit Uses Tokenised Equities as Underlyings for Structured Yield

Bybit Uses Tokenised Equities as Underlyings for Structured Yield

0
Explained: How BSE traded fewer contracts after CAS but premiums rose 75% in first week

Explained: How BSE traded fewer contracts after CAS but premiums rose 75% in first week

0
Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding (OTCMKTS:VXRT)

Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding (OTCMKTS:VXRT)

0
Advanced Micro Devices (AMD) Price Prediction: How Much a ,000 Investment Could Be Worth by 2031

Advanced Micro Devices (AMD) Price Prediction: How Much a $5,000 Investment Could Be Worth by 2031

August 8, 2026
Republican Party Displacement | Mises Institute

Republican Party Displacement | Mises Institute

August 8, 2026
Vanguard Chief Economist: AI and jobs, still in an ATM phase

Vanguard Chief Economist: AI and jobs, still in an ATM phase

August 8, 2026
Explained: How BSE traded fewer contracts after CAS but premiums rose 75% in first week

Explained: How BSE traded fewer contracts after CAS but premiums rose 75% in first week

August 8, 2026
Democrats’ Affordability Message Misses a Key Expense—Student Debt

Democrats’ Affordability Message Misses a Key Expense—Student Debt

August 8, 2026
Banks or NBFCs? DSP’s Preethi R S explains where she sees the best opportunities

Banks or NBFCs? DSP’s Preethi R S explains where she sees the best opportunities

August 8, 2026
FeeOnlyNews.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Advanced Micro Devices (AMD) Price Prediction: How Much a $5,000 Investment Could Be Worth by 2031
  • Republican Party Displacement | Mises Institute
  • Vanguard Chief Economist: AI and jobs, still in an ATM phase
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclaimers
  • About Us
  • Contact Us

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.